The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
COVID‐19 and the clinical hematology laboratory
Open accessAbstract
The ongoing COVID‐19 pandemic originated in Wuhan, Hubei Province, China, in December 2019. The etiologic agent is a novel coronavirus of presumed zoonotic origin with structural similarity to the viruses responsible for severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). Like SARS and MERS, COVID‐19 infection manifests most frequently with lower respiratory symptoms. A minority of patients progress to acute respiratory distress syndrome/ diffuse alveolar damage. In addition to its central role in the diagnosis of COVID‐19 infection, the clinical laboratory provides critical information to clinicians regarding prognosis, disease course, and response to therapy. The purpose of this review is to (a) provide background context about the origins and course of the pandemic, (b) discuss the laboratory's role in the diagnosis of COVID‐19 infection, (c) summarize the current state of biomarker analysis in COVID‐19 infection, with an emphasis on markers derived from the hematology laboratory, (d) comment on the impact of COVID‐19 on hematology laboratory safety, and (e) describe the impact the pandemic has had on organized national and international educational activities worldwide.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Corman, V. M., Landt, O., Kaiser, M., Molenkamp, R., Meijer, A., Chu, D. K., Bleicker, T., Brünink, S., Schneider, J., Schmidt, M. L., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.3.2000045 · Cited by 7,344
Tang, N., Li, D., Wang, X., & Sun, Z. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14768 · Cited by 5,662
Detection of SARS-CoV-2 in Different Types of Clinical Specimens
Wang, W., Xu, Y., Gao, R., Lu, R., Han, K., Wu, G., & Tan, W. (2020) · JAMA · doi:10.1001/jama.2020.3786 · Cited by 5,028
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775
Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy
Onder, G., Rezza, G., & Brusaferro, S. (2020) · JAMA · doi:10.1001/jama.2020.4683 · Cited by 4,171
Hematological Problems in Pediatric Intensive Care
Revel-Vilk, S., Cox, P., Robitaille, N., & Blanchette, V. (2014) · Pediatric and Adolescent Medicine · doi:10.1159/000350346 · Cited by 3,508
Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle
Lu, H., Stratton, C. W., & Tang, Y. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25678 · Cited by 3,504
Taylor, F., Toh, C.-H., Hoots, K., Wada, H., & Levi, M. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616068 · Cited by 2,285
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
Zhang, Y., Xiao, M., Zhang, S., Xia, P., Cao, W., Jiang, W., Chen, H., Ding, X., Zhao, H., Zhang, H., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2007575 · Cited by 2,179
Xu, X.-W., Wu, X.-X., Jiang, X.-G., Xu, K.-J., Ying, L.-J., Ma, C.-L., Li, S.-B., Wang, H.-Y., Zhang, S., Gao, H.-N., et al. (2020) · BMJ · doi:10.1136/bmj.m606 · Cited by 2,046
Grasselli, G., Pesenti, A., & Cecconi, M. (2020) · JAMA · doi:10.1001/jama.2020.4031 · Cited by 2,023
Xie, X., Zhong, Z., Zhao, W., Zheng, C., Wang, F., & Liu, J. (2020) · Radiology · doi:10.1148/radiol.2020200343 · Cited by 1,960
Lippi, G., Plebani, M., & Henry, B. M. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.03.022 · Cited by 1,706
Biosafety in microbiological and biomedical laboratories
Richmond, J. Y., & McKinney, R. W. (1999) · U.S. G.P.O. , For sale by the Supt. of Docs., U.S. G.P.O. eBooks · Cited by 1,483
Another Decade, Another Coronavirus
Perlman, S. (2020) · New England Journal of Medicine · doi:10.1056/nejme2001126 · Cited by 1,062
Laboratory abnormalities in patients with COVID-2019 infection
Lippi, G., & Plebani, M. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0198 · Cited by 1,020
Hematologic parameters in patients with COVID‐19 infection
Fan, B. E., Chong, V. C. L., Chan, S. S. W., Lim, G. H., Lim, K. G. E., Tan, G. B., Mucheli, S. S., Kuperan, P., & Ong, K. H. (2020) · American Journal of Hematology · doi:10.1002/ajh.25774 · Cited by 769
Lippi, G., Lavie, C. J., & Sanchis-Gomar, F. (2020) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2020.03.001 · Cited by 714
Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis
Lippi, G., & Plebani, M. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.03.004 · Cited by 652
Lippi, G., Simundic, A.-M., & Plebani, M. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0285 · Cited by 617
Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2
Yin, S., Huang, M., Li, D., & Tang, N. (2021) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02105-8 · Cited by 434
Lippi, G., & Plebani, M. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0240 · Cited by 414
Update on Procalcitonin Measurements
Meisner, M. (2014) · Annals of Laboratory Medicine · doi:10.3343/alm.2014.34.4.263 · Cited by 395
Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation
Ye, G., Pan, Z., Pan, Y., Deng, Q., Chen, L., Li, J., Li, Y., & Wang, X. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.001 · Cited by 353
What Other Countries Can Learn From Italy During the COVID-19 Pandemic
Boccia, S., Ricciardi, W., & Ioannidis, J. P. A. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.1447 · Cited by 335
Disseminated intravascular coagulation in patients with 2019‐nCoV pneumonia
Lillicrap, D. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14781 · Cited by 299
Laboratory abnormalities in children with novel coronavirus disease 2019
Henry, B. M., Lippi, G., & Plebani, M. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0272 · Cited by 251
Thrombocytopenia in patients with severe acute respiratory syndrome (review)
Yang, M., Ng, M. H., & Li, C. K. (2005) · Hematology · doi:10.1080/10245330400026170 · Cited by 185
Nicastri, E., Petrosillo, N., Ascoli Bartoli, T., Lepore, L., Mondi, A., Palmieri, F., D’Offizi, G., Marchioni, L., Murachelli, S., Ippolito, G., et al. (2020) · Infectious Disease Reports · doi:10.4081/idr.2020.8543 · Cited by 177
Morphological anomalies of circulating blood cells in COVID ‐19
Zini, G., Bellesi, S., Ramundo, F., & d’Onofrio, G. (2020) · American Journal of Hematology · doi:10.1002/ajh.25824 · Cited by 163
Self-citationPrognostic Factors for Severe Acute Respiratory Syndrome: A Clinical Analysis of 165 Cases
Zou, Z., Yang, Y., Chen, J.-M., Xin, S., Zhang, W., Zhou, X., Mao, Y., Hu, L., Liu, D., Chang, B., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/380973 · Cited by 60
Papa Giovanni XXIII Bergamo Hospital at the time of the COVID‐19 outbreak: Letter from the warfront…
Buoro, S., Marco, F. D., Rizzi, M., et al. (2020) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.13207 · Cited by 59
Cited by
COVID-19 and multiorgan failure: A narrative review on potential mechanisms
Mokhtari, T., Hassani, F., Ghaffari, N., Ebrahimi, B., Yarahmadi, A., & Hassanzadeh, G. (2020) · Journal of Molecular Histology · doi:10.1007/s10735-020-09915-3 · Cited by 439
Predicting Disease Severity and Outcome in COVID-19 Patients: A Review of Multiple Biomarkers
Tjendra, Y., Al Mana, A. F., Espejo, A. P., Akgun, Y., Millan, N. C., Gomez-Fernandez, C., & Cray, C. (2020) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2020-0471-sa · Cited by 264
Metadata
- Authors
- Frater, J. L., Zini, G., d’Onofrio, G., & Rogers, H. J.
- Venue
- International Journal of Laboratory Hematology
- Publisher
- Wiley
- Published
- 2020-06
- Volume
- 42
- Issue
- S1
- Pages
- 11-18
- ISSN
- 1751-5521 (ISSN-L)
- 1751-553X
- OpenAlex
- W3017189452
- Cited by
- 311
- References
- 37
- FWCI
- 8.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.